entrepreneur

Pascal Soriot

French businessman

3 members

What's driving coverage of Pascal Soriot right now?

3 memberscoverage spread: L25/C25/R50

Comments

Ask Genius by OpenServe:

Free account · your comment posts right after signup

Business
AstraZeneca Posts Q2 Beat, Reaffirms 2026 Outlook
AstraZeneca beat second-quarter profit expectations and reaffirmed its 2026 outlook despite concerns about future growth after a trial setback, as investors await further details on its earnings trajectory. Analysts are mixed but broadly positive, with several buy ratings and a focus on the upcoming Q2 results and oncology-driven revenue, amid a broader market backdrop of cautious trading ahead of earnings.
43 sources

Overview

Sir Pascal Claude Roland Soriot is a French-born Australian businessman and chief executive of the British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca.

From Wikipedia (CC BY-SA 4.0).

Pascal Soriot

Comments

AstraZeneca Posts Q2 Beat, Reaffirms 2026 Outlook

Pascal Soriot

Comments

AstraZeneca Posts Q2 Beat, Reaffirms 2026 Outlook

Pascal Soriot across IJR

Overview

Overview

Pascal Soriot across IJR